New York State Common Retirement Fund
UNCY icon

New York State Common Retirement Fund’s Unicycive Therapeutics UNCY Stock Holding History

New York State Common Retirement Fund’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.5K Buy
+6,500
New +$47.9K ﹤0.01% 3083

Other funds holding UNCY

CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

New York State Common Retirement Fund's UNCY Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 6,500 shares worth $30.5K. The stake represents ﹤0.01% of the portfolio and ranks #3083 among its holdings.

10 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • New York State Common Retirement Fund held 6,500 shares of Unicycive Therapeutics worth $30.5K as of Q2 2026.
  • Unicycive Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3083 holding.
  • 10 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.